Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Items 201–300 of 875
Nagar, M., Vernitsky, H., Cohen, Y., Dominissini, D., Berkun, Y., Rechavi, G., Amariglio, N., & Goldstein, I. (2008) · International Immunology · doi:10.1093/intimm/dxn062 · Cited by 87
Regulatory T cells Versus Th17: Differentiation of Th17 Versus Treg, Are They Mutually Exclusive?
Zheng, S. G. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_6 · Cited by 78
“Recent data demonstrate that FOXP3 (FOXP3 for human cells and Foxp3 for mouse cells) may be upregulated in rapidly proliferating human T cells and might be viewed as an activation marker for human T cells [8].”
BackgroundNigam, P., Velu, V., Kannanganat, S., Chennareddi, L. S., Kwa, S., Siddiqui, M., & Amara, R. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902955 · Cited by 83
“These FOXP3 expressing activated T cells possess the classic phenotype of Tregs, however, may (20) or may not (17, 18) possess suppressive function.”
BackgroundNanke, Y., Kotake, S., Goto, M., Ujihara, H., Matsubara, M., & Kamatani, N. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0064-x · Cited by 75
FOXP3+ regulatory T cells: From suppression of rejection to induction of renal allograft tolerance
Dummer, C. D., Carpio, V. N., Gonçalves, L. F. S., Manfro, R. C., & Veronese, F. V. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.08.009 · Cited by 80
Chen, L. C., Delgado, J. C., Jensen, P. E., & Chen, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901081 · Cited by 79
d’Hennezel, E., Yurchenko, E., Sgouroudis, E., Hay, V., & Piccirillo, C. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100269 · Cited by 73
GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients
Hjorth, M., Axelsson, S., Rydén, A., Faresjö, M., Ludvigsson, J., & Casas, R. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.10.004 · Cited by 77
The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
Frafjord, A., Buer, L., Hammarström, C. L., Aamodt, H., Woldbæk, P. R., Brustugun, O. T., Helland, Å., Øynebråten, I., & Corthay, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.764596 · Cited by 82
“Most human CD4 and CD8 T cells have been reported to upregulate FOXP3 upon activation (48, 57, 58).”
BackgroundRapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells
Wang, C., Yi, T., Qin, L., Maldonado, R. A., von Andrian, U. H., Kulkarni, S., Tellides, G., & Pober, J. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66204 · Cited by 73
“In humans, FoxP3 is not an exclusive marker of Tregs, as it is also transiently expressed on activated conventional CD4 + T cells (48, 49).”
Pinheiro, D., Singh, Y., Grant, C. R., Appleton, R. C., Sacchini, F., Walker, K. R. L., Chadbourne, A. H., Palmer, C. A., Armitage‐Chan, E. A., Thompson, I., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03346.x · Cited by 72
IL‐15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3
Imamichi, H., Sereti, I., & Lane, H. C. (2008) · European Journal of Immunology · doi:10.1002/eji.200737607 · Cited by 82
Barzaghi, F., Passerini, L., Gambineri, E., Mannurita, S. C., Cornu, T. I., Kang, E., Choe, Y. H., Cancrini, C., Corrente, S., Ciccocioppo, R., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.12.009 · Cited by 76
“These data suggest that, in the presence of activated Teff cells, transiently expressing CD25 and FOXP3 [24,35], flow cytometric analysis loses specificity to quantify peripheral bona fide Treg cells.”
BackgroundInfluentialSelf-citationBonelli, M. M., Smolen, J. S., & Scheinecker, C. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117135 · Cited by 74
Ullah, U., Andrabi, S. B. A., Tripathi, S. K., Dirasantha, O., Kanduri, K., Rautio, S., Groß, C. C., Lehtimäki, S., Bala, K., Tuomisto, J. E. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.070 · Cited by 75
“In humans, T cell receptor (TCR) stimulation leads to transient expression of FOXP3 (Allan et al., 2007) without any suppressive function.”
BackgroundLiu, Y., Mikrani, R., Xie, D., Wazir, J., Shrestha, S., Ullah, R., Baig, M. M. F. A., Ahmed, A., Srivastava, P. K., Thapa, K. B., et al. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12517 · Cited by 82
Fc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T Cells
Nagata, S., Ise, T., & Pastan, I. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802230 · Cited by 74
“Differences between human nTreg cells and mouse nTreg cells have been repeatedly reported, especially as to CD25 expression level and Foxp3 expression (20, 22, 23, 46).”
BackgroundPion, M., Jaramillo-Ruiz, D., Martínez, A., Muñoz‐Fernández, M. Á., & Correa‐Rocha, R. (2013) · AIDS · doi:10.1097/qad.0b013e32836253fd · Cited by 84
“The principal difficulty when defining the Treg functional population is that Foxp3 can also be induced in peripheral naive CD4þCD25 T cells [17], but it confers neither stable expression of Foxp3 [18] nor suppressive activity [19,20].”
BackgroundLi, S., Floess, S., Hamann, A., Gaudieri, S., Lucas, A., Hellard, M., Roberts, S., Paukovic, G., Plebanski, M., Loveland, B. E., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000707 · Cited by 71
“The transient expression of FOXP3 by activated human conventional T cells [15,16] further complicates the interpretation of human data.”
BackgroundAlternative Splicing of FOXP3—Virtue and Vice
Mailer, R. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00530 · Cited by 76
FOXP3+CD25− Tumor Cells with Regulatory Function in Sézary Syndrome
Heid, J. B., Schmidt, A., Oberle, N., Goerdt, S., Krammer, P. H., Suri‐Payer, E., & Klemke, C. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.175 · Cited by 72
“It was recently shown and confirmed by us (Figures 2c and 4) that activated human Tcon cells transiently express FOXP3 (Allan et al., 2007) and can gain suppressive abilities (Pillai et al.”
BackgroundResultHuman Colonic Myofibroblasts Promote Expansion of CD4+ CD25high Foxp3+ Regulatory T Cells
Pinchuk, I. V., Beswick, E. J., Saada, J. I., Boya, G., Schmitt, D. A., Raju, G. S., Brenmoehl, J., Rogler, G., Reyes, V. E., & Powell, D. W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.059 · Cited by 81
Duggleby, R. C., Danby, R., Madrigal, J. A., & Saudemont, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00252 · Cited by 79
“When comparing naive and memory conventional T cells (Tcons), it has been noted in murine studies that naive Tcons are the main source of alloreactive cells (51).”
BackgroundInfluentialCari, L., Rosa, F. D., Nocentini, G., & Riccardi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051142 · Cited by 77
Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells
Long, S. A., & Buckner, J. H. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.12.012 · Cited by 72
Zhuo, C., Xu, Y., Ying, M., Li, Q., Huang, L., Li, D., Cai, S., & Li, B. (2015) · Immunologic Research · doi:10.1007/s12026-014-8616-y · Cited by 77
“development [40, 55].”
Sempere-Ortells, J. M., Pérez-García, V., Marín-Alberca, G., Peris-Pertusa, A., Benito, J. M., de la Calle, F. M. M., Zubcoff, J., & Navarro-Blasco, F. J. (2009) · Autoimmunity · doi:10.3109/08916930903061491 · Cited by 72
“Increased FoxP3 expression in CD4þ and CD4þCD25low T cells might be linked to their activation state [42,43].”
BackgroundComparison of stable human Treg and Th clones by transcriptional profiling
Stockis, J., Fink, W., François, V., Connerotte, T., de Smet, C., Knoops, L., van der Bruggen, P., Boon, T., Coulie, P. G., & Lucas, S. (2009) · European Journal of Immunology · doi:10.1002/eji.200838807 · Cited by 69
Verma, N. D., Lam, A. D., Chiu, C., Tran, G. T., Hall, B. M., & Hodgkinson, S. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-88448-5 · Cited by 86
Therapeutic potential of TGF-β-induced CD4+Foxp3+regulatory T cells in autoimmune diseases
Zhou, X., Kong, N., Zou, H., Brand, D. D., Li, X., Liu, Z., & Zheng, S. G. (2010) · Autoimmunity · doi:10.3109/08916931003782163 · Cited by 73
“[12] Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK.”
Identification and characterization of Foxp3+ γδ T cells in mouse and human
Kang, N., Tang, L., Li, X., Wu, D., Li, W., Chen, X., Cui, L., Ba, D., & He, W. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.06.005 · Cited by 73
“[6] Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, et al.”
InfluentialSun, L., Jin, H., & Li, H. (2016) · Oncotarget · doi:10.18632/oncotarget.8753 · Cited by 79
“TGF-β inhibits Teffs proliferation and cytokines production [94].”
BackgroundInfluentialAre rats more human than mice?
Wildner, G. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.09.002 · Cited by 67
Regulatory T cells as therapeutic cells
Sagoo, P., Lombardi, G., & Lechler, R. I. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328317a476 · Cited by 75
Kanakry, C. G., Hess, A. D., Gocke, C. D., Thoburn, C. J., Kos, F. J., Meyer, C. F., Briel, J., Luznik, L., Smith, B. D., Levitsky, H. I., et al. (2010) · Blood · doi:10.1182/blood-2010-04-277939 · Cited by 74
Ladányi, A., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejôs, Z., Gaudi, I., & Tímár, J. (2010) · Pathology & Oncology Research · doi:10.1007/s12253-010-9254-x · Cited by 82
“On the other hand, in recent studies it became clear that the role of human FOXP3 is different from that of its murine counterpart, being a consequence of activation status, and responsible for an anergic phenotype, but not necessarily for a regulatory function of cells that express it [4, 26, 28, 34–36].”
BackgroundRestoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells
Kumar, P., Saini, S., Khan, S. M., Lele, S. S., & Prabhakar, B. S. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.09.008 · Cited by 77
Allergen provocation increases TH2‐cytokines and FOXP3 expression in the asthmatic lung
Thunberg, S., Gafvelin, G., Nord, M., Grönneberg, R., Grünewald, J., Eklúnd, A., & van Hage, M. (2010) · Allergy · doi:10.1111/j.1398-9995.2009.02218.x · Cited by 74
Zemmour, D., Charbonnier, L., Léon, J., Six, E. M., Keleş, S., Delville, M., Benamar, M., Barış, S., Zuber, J., Chen, K., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00910-8 · Cited by 69
Sanda, S., Roep, B. O., & von Herrath, M. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.12.003 · Cited by 72
Fenton, T. M., Kelly, A., Shuttleworth, E. E., Smedley, C., Atakilit, A., Powrie, F., Campbell, S., Nishimura, S. L., Sheppard, D., Levison, S., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.94 · Cited by 64
Ebert, L. M., MacRaild, S., Zanker, D. J., Davis, I. D., Cebon, J. S., & Chen, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048424 · Cited by 67
“previous studies showing that the acquisition of these markers by Teff is temporary, and expression is largely lost by day 10 of culture [12,27,28,30].”
BackgroundCD4 + CD25 low GITR + cells: A novel human CD4 + T‐cell population with regulatory activity
Bianchini, R., Bistoni, O., Alunno, A., Petrillo, M. G., Ronchetti, S., Sportoletti, P., Bartoloni, E., Nocentini, G., Gerli, R., & Riccardi, C. (2011) · European Journal of Immunology · doi:10.1002/eji.201040943 · Cited by 68
Regulatory T cells: tolerance induction in solid organ transplantation
Vaikunthanathan, T., Safinia, N., Boardman, D. A., Lechler, R. I., & Lombardi, G. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12978 · Cited by 70
Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
Schulze, A. B., Evers, G., Görlich, D., Möhr, M., Marra, A., Hillejan, L., Rehkämper, J., Schmidt, L. H., & Heitkötter, B. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-19-3414a · Cited by 112
Strauss, L., Bergmann, C., & Whiteside, T. L. (2007) · International Journal of Cancer · doi:10.1002/ijc.23001 · Cited by 63
Regulatory T-Cell Function Is Impaired in Celiac Disease
Granzotto, M., Bo, S. D., Quaglia, S., Tommasini, A., Piscianz, E., Valencic, E., Ferrara, F., Martelossi, S., Ventura, A., & Not, T. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0501-x · Cited by 63
“Actually, there is still some controversy as to whether all the cells positive for FOXP3 and CD25 have to be considered Tregs [23, 24]; for example, FOXP3? cells after in vitro stimulation could represent either activated or regulatory T-cells, with the latter having higher levels of FOXP3 expression [ 24 ].”
BackgroundNgalamika, O., Liang, G., Zhao, M., Yu, X., Yang, Y., Yin, H., Liu, Y., Yung, S., Chan, T. M., & Lu, Q. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.938165 · Cited by 62
“In addition, transient FOXP3 expression in cells other than natural Tregs is not always associated with a suppressive capacity (Allan et al., 2007).”
BackgroundBending, D., Pesenacker, A. M., Ursu, S., Wu, Q., Lom, H., Thirugnanabalan, B., & Wedderburn, L. R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400599 · Cited by 62
“Because T cell activation can elicit FOXP3 expression in Tcons (9), we wanted to determine the frequency of bona fide FOXP3 Tregs at the inflamed site.”
BackgroundEmpowering Regulatory T Cells in Autoimmunity
Kasper, I. R., Apostolidis, S. A., Sharabi, A., & Tsokos, G. C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.003 · Cited by 69
“Neither CD25 nor FoxP3 are perfect markers identifying Tregs because CD25 can be readily expressed in antigen or mitogen-stimulated T cells and effector T cells can express FoxP3 transiently in humans and mice [7, 8].”
BackgroundMolecular Determinants of Regulatory T Cell Development: The Essential Roles of Epigenetic Changes
Kitagawa, Y., Ohkura, N., & Sakaguchi, S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00106 · Cited by 61
“Some of the human naïve T cells and effector T cells are capable of expressing Foxp3 in response to TCR activation (Allan et al., 2007).”
BackgroundWhat causes relapses of autoimmune diseases? The etiological role of autoreactive T cells
Wildner, G., & Kaufmann, U. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.04.001 · Cited by 69
IPEX syndrome from diagnosis to cure, learning along the way
Bacchetta, R., & Roncarolo, M. G. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.11.021 · Cited by 66
Self-citationBroady, R., Yu, J., & Levings, M. K. (2009) · Blood · doi:10.1182/blood-2009-04-214437 · Cited by 60
Self-citationVariation of Tumor-Infiltrating Lymphocytes in Human Cancers: Controversy on Clinical Significance
Sasada, T., & Suekane, S. (2011) · Immunotherapy · doi:10.2217/imt.11.106 · Cited by 61
Mackroth, M. S., Malhotra, I. J., Mungai, P., Koech, D., Muchiri, E. M., & King, C. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001188 · Cited by 73
“duced in effector T cells (Teff) upon activation in vitro (39), it remains unclear whether these cells are activated or directly suppressive.”
BackgroundAbnormal CTLA‐4 function in T cells from patients with systemic lupus erythematosus
Jury, E. C., Flores‐Borja, F., Kalsi, H. S., Lazarus, M., Isenberg, D. A., Mauri, C., & Ehrenstein, M. R. (2010) · European Journal of Immunology · doi:10.1002/eji.200939781 · Cited by 72
Sideras, K., Galjart, B., Vasaturo, A., Pedroza‐González, A., Biermann, K., Mancham, S., Nigg, A. L., Hansen, B. E., Stoop, H., Zhou, G., et al. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25091 · Cited by 68
“For example, FoxP3 can in humans, in contrast to mice, also be expressed by activated helper T-cells.(26,27) In addition, activation-induced FoxP3 in human Teffector cells does not suppress proliferation or cytokine production.”
BackgroundColeman, M. M., Finlay, C. M., Moran, B., Keane, J., Dunne, P. J., & Mills, K. H. G. (2011) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2011.00927.x · Cited by 60
“Activated human T cells transiently express FoxP3, making it difficult to differentiate between Treg and activated T cells during an immune response (Allan et al., 2007).”
BackgroundRegulatory T Cells: Banned Cells for Decades
Loser, K., & Beissert, S. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.375 · Cited by 65
“of Foxp3 expression between mice and humans, and, furthermore, suggesting that FOXP3 is less reliable in defining human Tregs than mouse Tregs (Allan et al., 2007; Tran et al., 2007; Miyara et al., 2009).”
BackgroundAdipose‐tissue regulatory T cells: Critical players in adipose‐immune crosstalk
Becker, M., Levings, M. K., & Daniel, C. (2017) · European Journal of Immunology · doi:10.1002/eji.201646739 · Cited by 59
Self-citationControl of tissue‐localized immune responses by human regulatory T cells
Pesenacker, A. M., Broady, R. C., & Levings, M. K. (2014) · European Journal of Immunology · doi:10.1002/eji.201344205 · Cited by 58
Self-citationThe Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
Bayati, F., Mohammadi, M., Valadi, M., Jamshidi, S., Foma, A. M., & Sharif‐Paghaleh, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585819 · Cited by 68
“marker by itself, as it applies to any other cell markers used to recognize the cells such as Foxp3 (31), Neuropilin (NRP-1) (32) and Helios (33).”
BackgroundBarnas, J. L., Simpson-Abelson, M. R., Brooks, S. P., Kelleher, R. J., & Bankert, R. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000896 · Cited by 62
“Attempts to explore this possibility were confounded by the fact that human T lymphocytes transiently express Foxp3 upon activation (34, 35).”
BackgroundZhou, J., Bashey, A., Zhong, R., Corringham, S., Messer, K. S., Pu, M., Ma, W., Chut, T., Soiffer, R. J., Mitrovich, R., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.08.005 · Cited by 59
Regulatory T cells in inflammatory skin disease: from mice to humans
Kalekar, L. A., & Rosenblum, M. D. (2019) · International Immunology · doi:10.1093/intimm/dxz020 · Cited by 69
HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection
Kared, H., Lelièvre, J., Donkova-Petrini, V., Aouba, A., Melica, G., Balbo, M., Weiss, L., & Lévy, Y. (2008) · AIDS · doi:10.1097/qad.0b013e328319edc0 · Cited by 64
Suppression by human FOXP3 + regulatory T cells requires FOXP3-TIP60 interactions
Bin Dhuban, K., d’Hennezel, E., Nagai, Y., Xiao, Y., Shao, S., Istomine, R., Alvarez, F., Ben-Shoshan, M., Ochs, H., Mazer, B., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai9297 · Cited by 57
Diedrichs‐Möhring, M., Kaufmann, U., & Wildner, G. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.02.003 · Cited by 62
“Foxp3 expression during T cell activation (Allan et al., 2007), MHCclass II expression on activated T cells (Gansbacher and Zier, 1989; Taams et al.”
BackgroundRegulatory T cells in breast cancer as a potent anti-cancer therapeutic target
Hashemi, V., Maleki, L. A., Esmaily, M., Masjedi, A., Ghalamfarsa, G., Namdar, A., Yousefi, M., Yousefi, B., & Jadidi‐Niaragh, F. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106087 · Cited by 61
Mercer, F. K., & Unutmaz, D. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_4 · Cited by 61
Hombach, A. A., Kofler, D., Hombach, A., Rappl, G., & Abken, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7924 · Cited by 56
Belle, T. L. V., Vanherwegen, A.-S., Feyaerts, D., Clercq, P. D., Verstuyf, A., Korf, H., Gysemans, C. A., & Mathieu, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109194 · Cited by 63
“can transiently express FOXP3 at a low level without acquiring suppressive activity [38].”
BackgroundMailer, R. K., Falk, K., & Rötzschke, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006104 · Cited by 67
“to by induced in human T cells upon activation [11,25].”
BackgroundBronchoalveolar Immunologic Profile of Acute Human Lung Transplant Allograft Rejection
Gregson, A. L., Hoji, A., Saggar, R., Ross, D. J., Kubak, B., Jamieson, B. D., Weigt, S. S., Lynch, J. P., Ardehali, A. A., Belperio, J. A., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e318169bd85 · Cited by 56
“We cannot exclude the possibility that the cells being defined as Treg included activated CD4 helper T lymphocytes, because CD25 and FoxP3 are not specific markers for Treg, and can be expressed in the normal course of T cell activation (23, 24).”
BackgroundKluger, M. A., Meyer, M. C., Nosko, A., Goerke, B., Luig, M., Wegscheid, C., Tiegs, G., Stahl, R. A. K., Panzer, U., & Steinmetz, O. M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090880 · Cited by 61
Sprangers, B., DeWolf, S., Savage, T. M., Morokata, T., Obradović, A., LoCascio, S. A., Shonts, B. A., Zuber, J., Lau, S. P., Shah, R., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14251 · Cited by 59
“Tregs express high levels of CD25 (15, 16) and lack cell surface CD127 (IL-7 receptor a-chain) expression (17, 18).”
The TNFRSF members CD27 and OX40 coordinately limit T H 17 differentiation in regulatory T cells
Remedios, K. A., Zirak, B., Sandoval, P. M., Lowe, M. M., Boda, D. P., Henley, E., Bhattrai, S., Scharschmidt, T. C., Liao, W. J., Naik, H. B., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aau2042 · Cited by 63
Targeting regulatory T cells for immunotherapy in melanoma
Huang, L., Guo, Y., Liu, S., Wang, H., Zhu, J., Ou, L., & Xu, X. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00038-z · Cited by 61
“LAG-3 are also used as Treg markers [28, 29].”
BackgroundFOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
Ohkura, N., Hamaguchi, M., & Sakaguchi, S. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.004 · Cited by 60
CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection
Simonetta, F., & Bourgeois, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00215 · Cited by 61
“While FOXP3 is to date the most specific marker for Treg identification in mice, in humans the situation is more complex, as the expression of FoxP3 is also observed in some conventional CD4+CD25−T cells upon activation (14).”
BackgroundRegulatory T cells: Possible mediators for the anti-inflammatory action of statins
Shahbaz, S. K., Sadeghi, M., Koushki, K., Penson, P. E., & Sahebkar, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104469 · Cited by 63
“Immune dysregulation, poly endocrinopathy and enteropathy, X-linked syndrome (IPEX) are severe autoimmune disorders caused by Foxp3 dysfunction [99], and serve to highlight the importance of this regulatory pathway.”
BackgroundHuman CCR4+CCR6+Th17 Cells Suppress Autologous CD8+ T Cell Responses
Zhao, F., Hoechst, B., Gamrekelashvili, J., Ormandy, L. A., Voigtländer, T., Wedemeyer, H. H., Ylaya, K., Wang, X. W., Hewitt, S. M., Manns, M. P., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102918 · Cited by 64
IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis
Barzaghi, F., & Passerini, L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.612760 · Cited by 55
“Role of FOXP3 Beyond the Regulatory T-Cell Compartment Although originally described as exclusively expressed by Tregs (8), transient FOXP3 expression can be induced by activation of T-conventional cells, which do not undergo Treg reprogramming (47).”
BackgroundSelf-citationAntvorskov, J. C., Fundová, P., Buschard, K., & Funda, D. P. (2012) · Immunology · doi:10.1111/imm.12007 · Cited by 66
T Regulatory Cells in Cord Blood—FOXP3 Demethylation as Reliable Quantitative Marker
Liu, J., Lluis, A., Illi, S., Layland, L. E., Olek, S., von Mutius, E., & Schaub, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013267 · Cited by 54
“It is controversial whether all activated FOXP3 T-cells have similar suppressive capability [26–28].”
BackgroundBenito, M., García-Carmona, Y., Balsa, A., de Ayala, C. P., Cobo‐Ibáñez, T., Martín-Mola, E., & Miranda‐Carús, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900007 · Cited by 62
“This is in agreement with published data indicating that stimulated Treg show an enhanced suppressive capacity, and that their increased FoxP3 expression remains higher when compared with induced FoxP3 levels in stimulated Tresp (35).”
ResultKarlsson, I., Malleret, B., Brochard, P., Delache, B., Calvo, J., Grand, R. L., & Vaslin, B. (2007) · Journal of Virology · doi:10.1128/jvi.01466-07 · Cited by 56
“We cannot exclude the possibility that FoxP3 is a marker of activation, as recently described (2).”
BackgroundPekiner, F. N., Aytuğar, E., Demirel, G. Y., & Borahan, M. O. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01061.x · Cited by 55
Promises and paradoxes of regulatory T cells in inflammatory bowel disease
Lord, J. D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11236 · Cited by 62
Flanagan, K. L., Halliday, A., Burl, S., Landgraf, K., Jagne, Y. J., Noho‐Konteh, F., Townend, J., Miles, D. J. C., van der Sande, M., Whittle, H., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200939638 · Cited by 53
Beavis, P. A., Gregory, B., Green, P. A., Cribbs, A. P., Kennedy, A., Amjadi, P., Palfreeman, A. C., Feldmann, M., & Brennan, F. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112722108 · Cited by 56
“Further, this was achieved despite using CD4 memory lymphocytes, which are predominant in this tissue (53), whereas it is the CD4CD45RA population that is most amenable to adopting Treg function after ectopic foxp3 expression (54).”
MethodNunzio, S. D., Cecconi, M., Passerini, L., McMurchy, A. N., Baron, U., Türbachova, I., Vignola, S., Valencic, E., Tommasini, A., Junker, A., et al. (2009) · Blood · doi:10.1182/blood-2009-04-214593 · Cited by 54
Self-citationFunctional dynamics of Foxp3+ regulatory T cells in mice and humans
Dhuban, K. B., Kornete, M., Mason, E. S., & Piccirillo, C. A. (2014) · Immunological Reviews · doi:10.1111/imr.12168 · Cited by 60
“levels of FOXP3 upon activation, making them indistinguishable from Treg cells in inflammatory conditions (22, 164).”
BackgroundGPA33: A Marker to Identify Stable Human Regulatory T Cells
Opstelten, R., de Kivit, S., Slot, M. C., van den Biggelaar, M., Iwaszkiewicz‐Grześ, D., Gliwiński, M., Scott, A. M., Blom, B., Trzonkowski, P., Borst, J. G., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901250 · Cited by 57
Stoop, J. N., Claassen, M. A. A., Woltman, A. M., Binda, R. S., Kuipers, E. J., Janssen, H. L. A., Molen, R. G. V. D., & Boonstra, A. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.029 · Cited by 53
Shen, Y., Xu, H., Pan, X., Wu, W., Wang, H., Yan, L., Zhang, M., Liu, X., Xia, S., & Shao, Q. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5254 · Cited by 55
“It has been reported that activated T cells can upregulate the expression of Foxp3 (48,49).”
Improving the Efficacy of Regulatory T Cell Therapy
Baeten, P., Zeebroeck, L. V., Kleinewietfeld, M., Hellings, N., & Broux, B. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08866-1 · Cited by 55
Buckner, J. H., & Ziegler, S. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.014 · Cited by 52
Passerini, L., Olek, S., Nunzio, S. D., Barzaghi, F., Hambleton, S., Abinun, M., Tommasini, A., Vignola, S., Cipolli, M., Amendola, M., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.010 · Cited by 52
Self-citation
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.